Home Graves Orbitopathy
Article Publicly Available

Graves Orbitopathy

  • Stefano Natali and Paul Shogan
Published/Copyright: June 1, 2020

A 67-year-old woman presented to her gastroenterologist with 30 lb of unexplained weight loss, anxiety, and bilateral eyelid swelling with tenderness over a 5-month period. Her medical history included hypertension, stroke, and tobacco use. Esophagogastroduodenoscopy, colonoscopy, and abdominopelvic computed tomography (CT) results were unremarkable. CT of the orbit and sella turcica with and without contrast demonstrated bilateral exophthalmos with symmetric enlargement of the inferior and medial rectus muscles of both orbits (image A and image B), compatible with thyroid-associated orbitopathy.

It is estimated that Graves orbitopathy (GO) is prevalent in only 20% to 25% of patients with Graves disease.1 Imaging demonstrates bilateral symmetric enlargement of the extraocular muscles (EOMs), most commonly affecting the inferior and medial rectus.2 A 2017 study3 was successful in quantifying the severity of active disease by using CT parameters to demonstrate increases in volumetric measurements of EOM and orbital fat in those with active inflammation vs healthy controls. For the most accurate measurements, the axial plane is preferred.4 The clinical activity score assesses GO severity by assigning a point for each pertinent clinical sign of inflammation. This score can be directly correlated to the EOM-to-total orbital ratio; when a patient's clinical signs improve, the ratio diminishes.5


From the Edward Via College of Osteopathic Medicine–Carolinas Campus and the Regional Medical Center in Orangeburg, South Carolina.
Financial Disclosures: None reported.
Support: None reported.

*Address correspondence to Stefano Natali, OMS IV, 5770 SW 53rd Terrace, Miami, FL, 33155-6334. Email:


References

1. TandaML, PiantanidaE, LiparuloL, et al.. Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed graves' gyperthyroidism seen at a single center. J Clin EndocrinolMetab. 2013;98(4):1443-1449. doi:10.1210/jc.2012-3873Search in Google Scholar PubMed

2. GonçalvesAC, GebrimEM, MonteiroML. Imaging studies for diagnosing Graves' orbitopathy and dysthyroid optic neuropathy. Clinics (Sao Paulo). 2012;67(11):1327-1334. doi:10.6061/clinics/2012(11)18Search in Google Scholar PubMed PubMed Central

3. ByunJS, MoonNJ, Lee, JK. Quantitative analysis of orbital soft tissues on computed tomography to assess the activity of thyroid-associated orbitopathy. Graefe's Arch Clin Exp Ophthalmol. 2017;255(2):413-420. doi:10.1007/s00417-016-3538-0Search in Google Scholar PubMed

4. BijlsmaWR, MouritsMPl. Radiologic measurement of extraocular muscle volumes in patients with Graves' orbitopathy: a review and guideline.Orbit. 2006;25(2):83-91. doi:10.1080/01676830600675319Search in Google Scholar PubMed

5. Le MoliR, PluchinoA, MusciaV, et al.. Graves’ orbitopathy: extraocular muscle/total orbit area ratio is positively related to the clinical activity score. Eur J Ophthalmol. 2012;22(3):301-308. doi:10.5301/ejo.5000018Search in Google Scholar PubMed

Received: 2019-08-14
Accepted: 2019-08-22
Published Online: 2020-06-01
Published in Print: 2020-06-01

© 2020 American Osteopathic Association

Downloaded on 9.9.2025 from https://www.degruyterbrill.com/document/doi/10.7556/jaoa.2020.068/html
Scroll to top button